WO2025257254 - LIPASES AND LIPASE VARIANTS AND THE USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/257254
Publication Date
18.12.2025
International Application No.
PCT/EP2025/066263
International Filing Date
11.06.2025
Title **
[English]
LIPASES AND LIPASE VARIANTS AND THE USE THEREOF
[French]
LIPASES ET VARIANTS DE LIPASE ET LEUR UTILISATION
Applicants **
NOVOZYMES A/S
Inventors
TRUELSEN, Sigurd, Friis
MALTEN, Marco
VIND, Jesper
LANDVIK, Sara, Maria
SANDSTRÖM, Anders, Gunnar
CHRISTENSEN, Lars, Lehmann, Hylling
STRINGER, Mary, Ann
Priority Data
24181695.8
12.06.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2575 | |
| EPO | Filing, Examination, Granting | 10409 | |
| Japan | Filing, Examination, Granting | 2161 | |
| South Korea | Filing, Examination, Granting | 2056 | |
| USA | Filing, Examination, Granting | 10590 |
Total:
27,791
Contact Us
Abstract[English]
The present invention relates to lipases with a common three-dimensional structure, and variants thereof with an improved half-life improvement factor (HIF). The present invention also relates to polynucleotides encoding the lipases and variants, nucleic acid constructs, vectors, and host cells comprising the polynucleotides, compositions comprising the lipases or variants of the invention, and use of the variants.[French]
La présente invention concerne des lipases ayant une structure tridimensionnelle commune, et des variants de celles-ci ayant un facteur d'amélioration de demi-vie amélioré (HIF). La présente invention concerne également des polynucléotides codant pour les lipases et les variants, des constructions d'acides nucléiques, des vecteurs et des cellules hôtes comprenant les polynucléotides, des compositions comprenant les lipases ou les variants de l'invention, et l'utilisation des variants.